NO994395L - Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat - Google Patents
Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfatInfo
- Publication number
- NO994395L NO994395L NO994395A NO994395A NO994395L NO 994395 L NO994395 L NO 994395L NO 994395 A NO994395 A NO 994395A NO 994395 A NO994395 A NO 994395A NO 994395 L NO994395 L NO 994395L
- Authority
- NO
- Norway
- Prior art keywords
- tricalcium phosphate
- stable
- formulation containing
- solid formulation
- containing vitamin
- Prior art date
Links
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title abstract 3
- 235000005282 vitamin D3 Nutrition 0.000 title abstract 3
- 239000011647 vitamin D3 Substances 0.000 title abstract 3
- 229940021056 vitamin d3 Drugs 0.000 title abstract 3
- 239000001506 calcium phosphate Substances 0.000 title abstract 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title abstract 2
- 229940078499 tricalcium phosphate Drugs 0.000 title abstract 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 title abstract 2
- 235000019731 tricalcium phosphate Nutrition 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 206010006956 Calcium deficiency Diseases 0.000 abstract 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000020089 femoral neck fracture Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19710054A DE19710054A1 (de) | 1997-03-12 | 1997-03-12 | Pharmazeutische Zubereitung |
| PCT/EP1998/001208 WO1998040085A1 (de) | 1997-03-12 | 1998-03-04 | Stabile, feste zubereitung enthaltend vitamin d3 und tricalciumphosphat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994395D0 NO994395D0 (no) | 1999-09-10 |
| NO994395L true NO994395L (no) | 1999-09-10 |
Family
ID=7823015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994395A NO994395L (no) | 1997-03-12 | 1999-09-10 | Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0969849B1 (cs) |
| JP (1) | JP2001515486A (cs) |
| KR (1) | KR20000076042A (cs) |
| CN (1) | CN1249689A (cs) |
| AR (1) | AR010903A1 (cs) |
| AT (1) | ATE245425T1 (cs) |
| AU (1) | AU730675B2 (cs) |
| BR (1) | BR9808233A (cs) |
| CA (1) | CA2284183A1 (cs) |
| CZ (1) | CZ290991B6 (cs) |
| DE (2) | DE19710054A1 (cs) |
| DK (1) | DK0969849T3 (cs) |
| ES (1) | ES2201460T3 (cs) |
| HU (1) | HUP0002928A3 (cs) |
| NO (1) | NO994395L (cs) |
| PL (1) | PL335644A1 (cs) |
| PT (1) | PT969849E (cs) |
| SK (1) | SK121699A3 (cs) |
| WO (1) | WO1998040085A1 (cs) |
| ZA (1) | ZA982073B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479474B2 (en) * | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
| KR20040096589A (ko) * | 2002-02-20 | 2004-11-16 | 데이진 가부시키가이샤 | 비타민 ｄ3 유도체 및 이것을 사용하는 치료제 |
| EP1342796A3 (en) * | 2002-02-22 | 2004-01-02 | Teijin Limited | Compound for the treatment of paget's disease of bone |
| ES2393781T3 (es) * | 2003-05-07 | 2012-12-28 | Osteologix A/S | Combinaciones de estroncio para la profilaxis/tratamiento de afecciones de cartílagos y/o huesos |
| RU2268053C1 (ru) * | 2004-05-05 | 2006-01-20 | Григорий Николаевич Коныгин | Способ лечения гипокальциемий, остеопорозов, переломов |
| TR200900880A2 (tr) | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik bileşimler. |
| TR200900878A2 (tr) | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar |
| UA107599C2 (xx) | 2010-06-24 | 2015-01-26 | Стабілізована активна сполука | |
| AU2014201820B2 (en) | 2013-03-27 | 2016-05-19 | Psm Healthcare Limited | Stabilized vitamin D formulations |
| EP3042649A1 (en) * | 2015-01-09 | 2016-07-13 | S.B.M. S.r.l. | A composition, comprising tricalcium phosphate and gelatin, for treating dyspepsia and related disorders |
| CN105982071A (zh) * | 2015-02-05 | 2016-10-05 | 宁志伟 | 高剂量维生素d3口服制剂配方 |
| CN104800166B (zh) * | 2015-04-22 | 2017-11-10 | 青岛正大海尔制药有限公司 | 一种阿法骨化醇散剂及其制备方法 |
| CN113350374B (zh) * | 2021-06-23 | 2022-05-31 | 锦州医科大学 | 一种磷酸钙与维生素d复合微囊的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2525478B2 (ja) * | 1989-03-01 | 1996-08-21 | 帝人株式会社 | 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤 |
| JP3147249B2 (ja) * | 1992-03-11 | 2001-03-19 | コベルコ建機株式会社 | 走行用ポンプ圧の制御装置 |
| IL103224A (en) * | 1992-09-18 | 1998-08-16 | Teva Pharma | Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3 |
| US5548203A (en) * | 1994-06-29 | 1996-08-20 | Electric Power Research Institute, Inc. | Capacitor polarity-based var correction controller for resonant line conditions and large amplitude line harmonics |
| FR2724844B1 (fr) * | 1994-09-23 | 1997-01-24 | Innothera Lab Sa | Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation |
| IL115241A (en) * | 1994-09-26 | 2000-08-31 | American Cyanamid Co | Calcium dietary supplement |
-
1997
- 1997-03-12 DE DE19710054A patent/DE19710054A1/de not_active Withdrawn
-
1998
- 1998-03-04 AU AU64997/98A patent/AU730675B2/en not_active Ceased
- 1998-03-04 KR KR1019997008130A patent/KR20000076042A/ko not_active Withdrawn
- 1998-03-04 DE DE59809085T patent/DE59809085D1/de not_active Expired - Lifetime
- 1998-03-04 PL PL98335644A patent/PL335644A1/xx unknown
- 1998-03-04 AT AT98910722T patent/ATE245425T1/de active
- 1998-03-04 BR BR9808233-7A patent/BR9808233A/pt not_active IP Right Cessation
- 1998-03-04 SK SK1216-99A patent/SK121699A3/sk unknown
- 1998-03-04 HU HU0002928A patent/HUP0002928A3/hu unknown
- 1998-03-04 WO PCT/EP1998/001208 patent/WO1998040085A1/de not_active Ceased
- 1998-03-04 JP JP53916598A patent/JP2001515486A/ja active Pending
- 1998-03-04 PT PT98910722T patent/PT969849E/pt unknown
- 1998-03-04 CN CN98803171A patent/CN1249689A/zh active Pending
- 1998-03-04 DK DK98910722T patent/DK0969849T3/da active
- 1998-03-04 CA CA002284183A patent/CA2284183A1/en not_active Abandoned
- 1998-03-04 ES ES98910722T patent/ES2201460T3/es not_active Expired - Lifetime
- 1998-03-04 EP EP98910722A patent/EP0969849B1/de not_active Expired - Lifetime
- 1998-03-04 CZ CZ19993221A patent/CZ290991B6/cs not_active IP Right Cessation
- 1998-03-11 AR ARP980101087A patent/AR010903A1/es not_active Application Discontinuation
- 1998-03-11 ZA ZA982073A patent/ZA982073B/xx unknown
-
1999
- 1999-09-10 NO NO994395A patent/NO994395L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0002928A2 (hu) | 2001-02-28 |
| KR20000076042A (ko) | 2000-12-26 |
| NO994395D0 (no) | 1999-09-10 |
| AR010903A1 (es) | 2000-07-12 |
| HUP0002928A3 (en) | 2001-04-28 |
| BR9808233A (pt) | 2000-05-16 |
| AU6499798A (en) | 1998-09-29 |
| ZA982073B (en) | 1998-09-16 |
| DK0969849T3 (da) | 2003-11-03 |
| PT969849E (pt) | 2003-12-31 |
| ATE245425T1 (de) | 2003-08-15 |
| EP0969849B1 (de) | 2003-07-23 |
| AU730675B2 (en) | 2001-03-08 |
| JP2001515486A (ja) | 2001-09-18 |
| ES2201460T3 (es) | 2004-03-16 |
| PL335644A1 (en) | 2000-05-08 |
| WO1998040085A1 (de) | 1998-09-17 |
| CZ322199A3 (cs) | 2000-01-12 |
| EP0969849A1 (de) | 2000-01-12 |
| CZ290991B6 (cs) | 2002-11-13 |
| DE19710054A1 (de) | 1998-09-17 |
| SK121699A3 (en) | 2000-01-18 |
| DE59809085D1 (de) | 2003-08-28 |
| CN1249689A (zh) | 2000-04-05 |
| CA2284183A1 (en) | 1998-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994395L (no) | Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat | |
| BR9808348A (pt) | Alimento medicinal para diabéticos | |
| NO20063853L (no) | Kombinasjonsterapi for osteoporose | |
| AR015946A1 (es) | Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis | |
| BR0112094A (pt) | Produtos de confeitaria contendo ingredientes ativos | |
| YU18400A (sh) | Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja | |
| WO1999032135A8 (en) | Keratinocyte growth factor-2 formulations | |
| SE9901272D0 (sv) | New improved formulation | |
| ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
| MX9307569A (es) | Formulacion de mezcla seca para acidos bisfosfonicos. | |
| ATE162073T1 (de) | Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol | |
| DE60239343D1 (de) | Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff | |
| IL78342A (en) | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof | |
| BG100911A (en) | Biophosphonic acids-sontaining wet-granulated form | |
| BR9810832B1 (pt) | composição farmacêutica contendo como princìpios ativos vitamina d associada a um sal de cálcio, e, processos para a preparação de uma composição farmacêutica, para o tratamento de deficiências nutricionais de cálcio e vitamina d na velhice e para reduzir a perda de tecido ósseo ligada à idade e para evitar fraturas femurais e outras fraturas não vertebrais. | |
| WO1998058911A3 (en) | Prostaglandin agonists | |
| ES2129485T3 (es) | Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion. | |
| DE69919533D1 (de) | Proteinhaltige arzneimittel | |
| ITMI931649A1 (it) | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico | |
| DE69716469D1 (de) | Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol | |
| BR9608392A (pt) | Preparação multiparticulada de liberação controlada e forma de dosagem em tablete. | |
| DK0762883T3 (da) | Pyridylbisphosphonater til anvendelse som terapeutisk middel | |
| AR019025A1 (es) | Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado | |
| DE69915852D1 (de) | Lhrh-analoga zur behandlung der osteoporose | |
| FR2803521B1 (fr) | Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose |